• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Absci Corp (ABSI)

Common Shares
Sell: $2.98|Buy: $2.99|Change: 0.04 (-1.32%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cellline development into one simultaneous process.

Address




Website

https://www.absci.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Absci Corp Third Quarter Earnings Conference Call for 20262026-11-12T16:30:00
Absci Corp Third Quarter Earnings Results for 20262026-11-12T00:00:00
Absci Corp Second Quarter Earnings Conference Call for 20262026-08-12T16:30:00
Absci Corp Second Quarter Earnings Results for 20262026-08-12T00:00:00
Absci Corp Annual General Meeting for 20262026-06-11T09:00:00
Absci Corp First Quarter Earnings Conference Call for 20262026-05-13T16:30:00
Absci Corp First Quarter Earnings Results for 20262026-05-13T00:00:00
Absci Corp Fourth Quarter Earnings Conference Call for 20252026-03-18T16:30:00
Absci Corp Annual Report for 20252026-03-18T00:00:00
Absci Corp Fourth Quarter Earnings Results for 20252026-03-18T00:00:00

Previous key dates

NameKey Date
44(th) Annual J.P. Morgan Healthcare Conference2026-01-14T06:45:00
ABS-201 KOL Seminar (Anti-PRLR for Androgenetic Alopecia Program)2025-12-11T10:00:00
Jefferies Global Healthcare Conference2025-11-18T04:30:00
Absci Corp Third Quarter Earnings Conference Call for 20252025-11-12T16:30:00
Absci Corp Third Quarter Earnings Result for 20252025-11-12T00:00:00
Guggenheim Securities 2nd Annual Healthcare Innovation Conference2025-11-10T10:00:00
H.C. Wainwright 27th Annual Global Investment Conference2025-09-09T09:30:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-08T15:20:00
Absci Corp Second Quarter Earnings Conference Call for 20252025-08-12T16:30:00
Absci Corp Second Quarter Earnings Results for 20252025-08-12T00:00:00
Absci Corp Annual General Meeting for 20252025-06-11T09:00:00
Goldman Sachs 46th Annual Global Healthcare Conference2025-06-09T08:40:00
Jefferies Global Healthcare Conference2025-06-05T14:00:00
Absci Corp First Quarter Earnings Conference Call for 20252025-05-13T16:30:00
Absci Corp First Quarter Earnings Result for 20252025-05-13T00:00:00
24th Annual Needham Virtual Healthcare Conference2025-04-08T15:45:00
H.C. Wainwright 2nd Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference2025-04-02T10:30:00
virtual KeyBanc Capital Markets Healthcare Forum2025-03-19T09:00:00
Absci Corp Fourth Quarter Earnings Conference Call for 20242025-03-18T16:30:00
Absci Corp Annual Report for 20242025-03-18T00:00:00
Absci Corp Fourth Quarter Earnings Result for 20242025-03-18T00:00:00
TD Cowen 45th Annual Health Care Conference2025-03-03T15:10:00
Guggenheim Securities SMID Cap Biotech Conference2025-02-05T15:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.